JBS, Hims & Hers and Rocket Lab shares fall after results

JBS cited a difficult operating environment across several business units as third-quarter profit fell. Its stock dropped 7.3% to $12.16 in after-hours trading.

Hims & Hers Health’s shares slipped 2.8% to $22.30 after the company narrowed its sales outlook and reported an unexpected third-quarter loss, driven by higher costs.

Skydance said it plans to cut at least $6 billion in annual costs following its deal to combine Paramount and Warner Bros. Discovery. Third-quarter revenue fell short of analyst expectations, and shares declined 2.1% to $8.52 after Monday’s closing bell.

Rocket Lab reported a wider-than-expected third-quarter loss. Its shares fell 6.6% to $55.00.